000 | 01032 a2200313 4500 | ||
---|---|---|---|
005 | 20250518084300.0 | ||
264 | 0 | _c20201214 | |
008 | 202012s 0 0 eng d | ||
022 | _a1872-7980 | ||
024 | 7 |
_a10.1016/j.canlet.2020.02.002 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aXu, Shengchao | |
245 | 0 | 0 |
_aImmunotherapy for glioma: Current management and future application. _h[electronic resource] |
260 |
_bCancer letters _c04 2020 |
||
300 |
_a1-12 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 |
_aBrain Neoplasms _ximmunology |
650 | 0 | 4 | _aDisease Management |
650 | 0 | 4 |
_aGlioma _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunotherapy _xmethods |
650 | 0 | 4 | _aPrognosis |
700 | 1 | _aTang, Lu | |
700 | 1 | _aLi, Xizhe | |
700 | 1 | _aFan, Fan | |
700 | 1 | _aLiu, Zhixiong | |
773 | 0 |
_tCancer letters _gvol. 476 _gp. 1-12 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.canlet.2020.02.002 _zAvailable from publisher's website |
999 |
_c30621137 _d30621137 |